Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
<p>Abstract</p> <p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and sometimes the only curative therapy for patients with certain hematological diseases. Allo-HSCT has been practiced in China for approximately 30 years, and great improvements have...
Main Authors: | Lv Meng, Huang Xiao-Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://www.jhoonline.org/content/5/1/10 |
Similar Items
-
Analysis of Correlation between Body Mass Index and the Incidence of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Masoud Soleimani, et al.
Published: (2021-09-01) -
The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
by: Zhipeng Li, et al.
Published: (2024-04-01) -
Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS in vitro and correlates with inflammatory parameters and clinical severity
by: Bernardo López-Andrade, et al.
Published: (2024-03-01) -
IMPACT OF HLA-DPB1 INCOMPATIBILITY ON THE RESULTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM HLA-A-B-C–DRB1-DQB1-COMPATIBLE UNRELATED DONOR
by: E. G. Khamaganova, et al.
Published: (2018-05-01) -
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
by: Xiaoyu Zhang, et al.
Published: (2022-12-01)